National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 5192-5193 [05-1823]
Download as PDF
<![CDATA[
5192
Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Middle
Ear Clinical Center Review.
Date: February 28, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone conference call).
Contact Person: Da-yu Wu, PhD, Scientific
Review Administrator, Scientific Review
Branch, Division of Extramural Activities,
NIDCD, NIH, 6120 Executive Blvd., Suite
400C, Bethesda, MD 20892, 301–496–8683,
wudy@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1820 Filed 1–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meetings.
VerDate jul<14>2003
15:06 Jan 31, 2005
Jkt 205001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Training Grant and
Career Development Review Committee.
Date: February 17–18, 2005.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Raul A. Saavedra, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, NSC; 6001
Executive Blvd., Ste. 3208, Bethesda, MD
20892–9529, 301–496–9223,
saavedrr@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders C.
Date: February 24–25, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel at Pentagon City,
1250 South Hayes Street, Arlington, VA
22202.
Contact Person: Andrea Sawczuk, DDS,
PhD, Scientific Review Administrator,
Scientific Review Branch, Division of
Extramural Research, NINDS/NIH/DHHS,
6001 Executive Boulevard, Room #3208,
Bethesda, MD 20892, 301–496–0660,
sawczuka@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders B.
Date: February 24–25, 2005.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City, 2399 Jefferson
Davis Hwy, Arlington, VA 22202.
Contact Person: W. Ernest Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive
Boulevard, Suite 3208, MSC 9529, Bethesda,
MD 20892–9529, 301–496–4056.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders K.
Date: February 24–25, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Contact Person: Katherine M. Woodbury,
PhD, Scientific Review Administrator,
Scientific Review Branch, NINDS/NIH/
DHHS, Neuroscience Center, 6001 Executive
Boulevard, Suite 3208, MSC 9529, Bethesda,
MD 20892–9529, 301–496–9223.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group, Neurological Sciences and
Disorders A.
Date: March 3–4, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Newport Beach, 1107
Jamboree Road, Newport Beach, CA 92660.
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Boulevard, Suite
3208, MSC 9529, Bethesda, MD 20892–9529,
301–496–9223.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1822 Filed 1–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Transitional
Research for the Prevention and Control of
diabetes.
Date: March 23, 2005.
Time: 8 a.m. to 6 p.m.
E:\FR\FM\01FEN1.SGM
01FEN1
Federal Register / Vol. 70, No. 20 / Tuesday, February 1, 2005 / Notices
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda North Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Michele L. Barnard, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8898,@barnardmextra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1823 Filed 1–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 05–44, Review R03s.
Date: February 24, 2005.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone conference call).
Contact Person: Rebecca Roper, MS, MPH,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, 45 Center Dr., room 4AN32E,
Bethesda, MD 20892, 301 451–5096.
VerDate jul<14>2003
16:15 Jan 31, 2005
Jkt 205001
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 05–48, Review R13s.
Date: March 16, 2005.
Time: 11 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone conference call).
Contact Person: Sooyoun (Sonia) Kim, MS,
Associate SRA, Scientific Review Branch,
Division of Extramural Research, National
Inst of Dental & Craniofacial Research,
National Institutes of Health, Bethesda, MD
20892, 301 594–4827.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel, 05–47, Review R13s.
Date: March 29, 2005.
Time: 2 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892 (Telephone conference call).
Contact Person: Sooyoun (Sonia) Kim, MS,
Associate SRA, Scientific Review Branch,
Division of Extramural Research, National
Inst of Dental & Craniofacial Research,
National Institutes of Health, Bethesda, MD
20892, 301 594–4827.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1824 Filed 1–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
5193
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, HIV Vaccine Research and
Design, (HIVRAD).
Date: February 15–17, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Chevy Chase Holiday Inn, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Eleazar Cohen, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIAID/NIH/DHHS, Room 3129,
6700 B Rockledge Drive, Bethesda, MD
20892, 301 435–3564, ec17w@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–1825 Filed 1–31–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN RESOURCES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Large Scale Centers for the Protein
Structure Initiative.
Date: February 21–23, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: C Craig Hyde, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
E:\FR\FM\01FEN1.SGM
01FEN1
]]>Agencies
[Federal Register Volume 70, Number 20 (Tuesday, February 1, 2005)]
[Notices]
[Pages 5192-5193]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-1823]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Transitional Research
for the Prevention and Control of diabetes.
Date: March 23, 2005.
Time: 8 a.m. to 6 p.m.
[[Page 5193]]
Agenda: To review and evaluate grant applications.
Place: Marriott Bethesda North Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Michele L. Barnard, PhD, Scientific Review
Administrator, Review Branch, DEA, NIDDK, National Institutes of
Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892-5452,
(301) 594-8898,@barnardmextra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: January 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-1823 Filed 1-31-05; 8:45 am]
BILLING CODE 4140-01-M
